Taiwan · Delayed Price · Currency is TWD AnnJi Pharmaceutical Statistics
Total Valuation
TPEX:7754 has a market cap or net worth of TWD 5.18 billion. The enterprise value is 4.77 billion.
| Market Cap | 5.18B |
| Enterprise Value | 4.77B |
Important Dates
The next estimated earnings date is Wednesday, August 19, 2026.
| Earnings Date | Aug 19, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TPEX:7754 has 94.06 million shares outstanding. The number of shares has increased by 2.46% in one year.
| Current Share Class | 94.06M |
| Shares Outstanding | 94.06M |
| Shares Change (YoY) | +2.46% |
| Shares Change (QoQ) | +0.23% |
| Owned by Insiders (%) | 2.95% |
| Owned by Institutions (%) | 11.12% |
| Float | 49.85M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 5,404.51 |
| PB Ratio | 12.37 |
| P/TBV Ratio | 14.05 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.58, with a Debt / Equity ratio of 0.11.
| Current Ratio | 3.58 |
| Quick Ratio | 3.35 |
| Debt / Equity | 0.11 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.14 |
| Interest Coverage | -263.81 |
Financial Efficiency
Return on equity (ROE) is -87.38% and return on invested capital (ROIC) is -48.41%.
| Return on Equity (ROE) | -87.38% |
| Return on Assets (ROA) | -33.77% |
| Return on Invested Capital (ROIC) | -48.41% |
| Return on Capital Employed (ROCE) | -72.04% |
| Weighted Average Cost of Capital (WACC) | 2.55% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.00 |
| Inventory Turnover | 0.02 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +40.23% in the last 52 weeks. The beta is -0.31, so TPEX:7754's price volatility has been lower than the market average.
| Beta (5Y) | -0.31 |
| 52-Week Price Change | +40.23% |
| 50-Day Moving Average | 58.13 |
| 200-Day Moving Average | 55.13 |
| Relative Strength Index (RSI) | 44.84 |
| Average Volume (20 Days) | 128,581 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:7754 had revenue of TWD 959,000 and -405.97 million in losses. Loss per share was -4.23.
| Revenue | 959,000 |
| Gross Profit | 579,000 |
| Operating Income | -398.09M |
| Pretax Income | -405.97M |
| Net Income | -405.97M |
| EBITDA | -360.69M |
| EBIT | -398.09M |
| Loss Per Share | -4.23 |
Balance Sheet
The company has 460.27 million in cash and 46.30 million in debt, with a net cash position of 413.96 million or 4.40 per share.
| Cash & Cash Equivalents | 460.27M |
| Total Debt | 46.30M |
| Net Cash | 413.96M |
| Net Cash Per Share | 4.40 |
| Equity (Book Value) | 418.98M |
| Book Value Per Share | 4.28 |
| Working Capital | 354.04M |
Cash Flow
In the last 12 months, operating cash flow was -334.88 million and capital expenditures -2.25 million, giving a free cash flow of -337.13 million.
| Operating Cash Flow | -334.88M |
| Capital Expenditures | -2.25M |
| Depreciation & Amortization | 37.40M |
| Net Borrowing | -6.07M |
| Free Cash Flow | -337.13M |
| FCF Per Share | -3.58 |
Margins
| Gross Margin | 60.38% |
| Operating Margin | -41,510.74% |
| Pretax Margin | -42,332.12% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TPEX:7754 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.46% |
| Shareholder Yield | -2.46% |
| Earnings Yield | -7.83% |
| FCF Yield | -6.50% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |